Japanese deal for ProStrakan

Japanese group Kyowa Hakko Kirin has agreed to buy Scottish drug firm ProStrakan Group for £292m, marking a further expansion by Japan’s drug industry into foreign markets. The Japanese group will pay 130p a share in cash, a 41 per cent premium to ProStrakan’s share price on 12 November, the last business day before the start of the current offer period, the companies said yesterday.